Lonza | LONN - Operating Profit

Stock Price
517.80
Daily Change
-8.20 -1.56%
Monthly
-3.68%
Yearly
-15.53%
Q1 Forecast
512.24

Lonza reported CHF430M in Operating Profit for its fiscal semester ending in December of 2024.





Operating Profit Change Date
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 332M 85M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -543M 556M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 5.39B 5.34B Sep/2025
Demant DKK 2.09B 224M Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Geberit CHF 199.9M 4.4M Sep/2025
Genmab DKK 360M 172M Jun/2025
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
Hikma Pharmaceutical USD 187M 95M Jun/2025
Johnson Matthey GBP 142M 89M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Philips EUR 329M 159M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sika AG CHF 798.1M 93.6M Jun/2025
Smith & Nephew USD 440M 50M Dec/2025
Solvay EUR 138M 12M Sep/2025
UCB EUR 1B 678M Dec/2024